Yuichi Yamada

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Significance of Spread Through Air Spaces in Resected Pathological Stage I Lung Adenocarcinoma

Gouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa et al. · The Annals of Thoracic Surgery · 2018 · 127 citations

Surgical Oncology, Lung Deposition, Medicine +11

Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone

Hidetaka Yamamoto, Takeshi Iwasaki, Yuichi Yamada et al. · Human Pathology · 2017 · 120 citations

Tumor Biology, G34v Mutant-specific Antibodies, Diagnostic Utility +6

Computed tomography features of resected lung adenocarcinomas with spread through air spaces

Gouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa et al. · Journal of Thoracic and Cardiovascular Surgery · 2018 · 107 citations · Full text

Computed Tomography, Resected Lung Adenocarcinomas, Medical Imaging +9

Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1

Kunio Iura, Akira Maekawa, Kenichi Kohashi et al. · Human Pathology · 2016 · 106 citations

Tumor Biology, Cancer Immunosurveillance, Synovial Sarcoma +7